Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial

OBJECTIVE: To evaluate the safety and efficacy of a 5 mg sublingual dose of zolpidem, compared to a 10 mg oral dose, at bedtime and “as needed” following middle-of-the-night awakenings. METHODS: Participants were randomized into an oral group (oral zolpidem 10 mg and sublingual placebo at bedtime an...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Laura S., Otuyama, Leonardo J., Fumo-dos-Santos, Cristiane, Tufik, Sergio, Poyares, Dalva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115453/
https://www.ncbi.nlm.nih.gov/pubmed/31859791
http://dx.doi.org/10.1590/1516-4446-2019-0389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115453/
https://www.ncbi.nlm.nih.gov/pubmed/31859791
http://dx.doi.org/10.1590/1516-4446-2019-0389

Ejemplares similares